Press Release March 23, 2021CureVac's COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant (South African Variant) in Preclinical Challenge Study 0 0 Share
General Market News March 22, 2021CureVac Expands Late-Stage Trials Of COVID-19 Vaccine Candidate 0 0 Share
General Market News March 6, 2021From Pfizer to Moderna: who's making billions from Covid-19 vaccines? 0 0 Share
General Market News March 4, 2021Novartis Lends Support To Manufacture CureVac's COVID-19 Shots 0 0 Share
